Corruption and health expenditure in Italy
AbstractThe vulnerability of health sector to corruption lies in the complex interaction between the social environment and the institutional setting of health systems. We investigate this interaction in the case of Italy, speci�cally looking at the impact of corruption on health expenditure. In Italy corruption is a social phenomenon. Health sector has been often involved in corruption o¤ences and decentralized health expenditure is considerably out of control. We show that the impact of corruption on health expenditure is positive, along with ageing population, technological change and supply factors inducing demand in pharmaceuticals and hospitalization. Moreover, the empirical analysis demonstrates that corruption a¤ects pharmaceutical expenditure and accredited private hospital expenditure, suggesting implications for health governance and policy.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by University Library of Munich, Germany in its series MPRA Paper with number 43215.
Date of creation: 02 Dec 2012
Date of revision:
health expenditures; corruption; panel data; sur model;
Find related papers by JEL classification:
- H51 - Public Economics - - National Government Expenditures and Related Policies - - - Government Expenditures and Health
- H75 - Public Economics - - State and Local Government; Intergovernmental Relations - - - State and Local Government: Health, Education, and Welfare
- K14 - Law and Economics - - Basic Areas of Law - - - Criminal Law
This paper has been announced in the following NEP Reports:
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Baltagi, Badi H. & Moscone, Francesco, 2010.
"Health care expenditure and income in the OECD reconsidered: Evidence from panel data,"
Elsevier, vol. 27(4), pages 804-811, July.
- Badi H. Baltagi & Francesco Moscone, 2010. "Health Care Expenditure and Income in the OECD Reconsidered: Evidence from Panel Data," Center for Policy Research Working Papers 120, Center for Policy Research, Maxwell School, Syracuse University.
- Badi H. Baltagi & Francesco Moscone, 2009. "Health Care Expenditure and Income in the OECD Reconsidered: Evidence from Panel Data," Discussion Papers in Economics 09/5, Department of Economics, University of Leicester.
- Baltagi, Badi H. & Moscone, Francesco, 2010. "Health Care Expenditure and Income in the OECD Reconsidered: Evidence from Panel Data," IZA Discussion Papers 4851, Institute for the Study of Labor (IZA).
- Joan Costa Font & Jordi Pons Novell, 2005.
"Public Health Expenditure and Spatial Interactions in a Decentralized National Health System,"
Working Papers in Economics
139, Universitat de Barcelona. Espai de Recerca en Economia.
- Joan Costa-Font & Jordi Pons-Novell, 2007. "Public health expenditure and spatial interactions in a decentralized national health system," Health Economics, John Wiley & Sons, Ltd., vol. 16(3), pages 291-306.
- Luca Crivelli & Massimo Filippini & Ilaria Mosca, 2006. "Federalism and regional health care expenditures: an empirical analysis for the Swiss cantons," Health Economics, John Wiley & Sons, Ltd., vol. 15(5), pages 535-541.
- Lauridsen, Jorgen & Bech, Mickael & Lopez, Fernando & Mate Sanchez, Mariluz, 2008. "Geographic and Temporal Heterogeneity in Public Prescription Pharmaceutical Expenditures in Spain," The Review of Regional Studies, Southern Regional Science Association, vol. 38(1), pages 89-103.
- Khaleghian, Peyvand & Gupta, Monica Das, 2005. "Public management and the essential public health functions," World Development, Elsevier, vol. 33(7), pages 1083-1099, July.
- Ferrario, Caterina & Zanardi, Alberto, 2011. "Fiscal decentralization in the Italian NHS: What happens to interregional redistribution?," Health Policy, Elsevier, vol. 100(1), pages 71-80, April.
- Robalino, David A. & Picazo, Oscar F. & Voetberg, Albertus, 2001. "Does fiscal decentralization improve health outcomes? - evidence from a cross-country analysis," Policy Research Working Paper Series 2565, The World Bank.
- Carinci, Fabrizio & Caracci, Gianni & Di Stanislao, Francesco & Moirano, Fulvio, 2012. "Performance measurement in response to the Tallinn Charter: Experiences from the decentralized Italian framework," Health Policy, Elsevier, vol. 108(1), pages 60-66.
- Gian Paolo Barbetta & Gilberto Turati & Angelo M. Zago, 2007.
"Behavioral differences between public and private not-for-profit hospitals in the Italian national health service,"
John Wiley & Sons, Ltd., vol. 16(1), pages 75-96.
- Gian Paolo Barbetta & Gilberto Turati & Angelo Zago, 2004. "Behavioral Differences Between Public and Private Not-For-Profit Hospitals in the Italian National Health Service," Working Papers 12, University of Verona, Department of Economics.
- Bordignon, Massimo & Turati, Gilberto, 2009. "Bailing out expectations and public health expenditure," Journal of Health Economics, Elsevier, vol. 28(2), pages 305-321, March.
- Wallace E. Oates, 1999. "An Essay on Fiscal Federalism," Journal of Economic Literature, American Economic Association, vol. 37(3), pages 1120-1149, September.
- Del Monte, Alfredo & Papagni, Erasmo, 2001. "Public expenditure, corruption, and economic growth: the case of Italy," European Journal of Political Economy, Elsevier, vol. 17(1), pages 1-16, March.
- Maureen Lewis, 2006. "Governance and Corruption in Public Health Care Systems," Working Papers 78, Center for Global Development.
- Del Monte, Alfredo & Papagni, Erasmo, 2007. "The determinants of corruption in Italy: Regional panel data analysis," European Journal of Political Economy, Elsevier, vol. 23(2), pages 379-396, June.
- Di Matteo, Livio, 2000. "The determinants of the public-private mix in Canadian health care expenditures: 1975-1996," Health Policy, Elsevier, vol. 52(2), pages 87-112, June.
- Omar Azfar & Tugrul Gurgur, 2008. "Does corruption affect health outcomes in the Philippines?," Economics of Governance, Springer, vol. 9(3), pages 197-244, July.
- Matteo Maria. Galizzi & Simone Ghislandi & Marisa Miraldo, 2011. "Effects of Reference Pricing in Pharmaceutical Markets: A Review," PharmacoEconomics, Springer Healthcare | Adis, vol. 29(1), pages 17-33.
- Jose J. Martin Martin & M. Puerto Lopez del Amo Gonzalez & M. Dolores Cano Garcia, 2011. "Review of the literature on the determinants of healthcare expenditure," Applied Economics, Taylor & Francis Journals, vol. 43(1), pages 19-46.
- Jes�s Clemente & Carmen Marcuello & Antonio Monta�és, 2008. "Pharmaceutical expenditure, total health-care expenditure and GDP," Health Economics, John Wiley & Sons, Ltd., vol. 17(10), pages 1187-1206.
- Aleksandra Torbica & Giovanni Fattore, 2005. "The “Essential Levels of Care” in Italy: when being explicit serves the devolution of powers," The European Journal of Health Economics, Springer, vol. 6(1), pages 46-52, November.
- Di Matteo, Livio & Di Matteo, Rosanna, 1998. "Evidence on the determinants of Canadian provincial government health expenditures: 1965-1991," Journal of Health Economics, Elsevier, vol. 17(2), pages 211-228, April.
- Toke S. Aidt, 2003. "Economic analysis of corruption: a survey," Economic Journal, Royal Economic Society, vol. 113(491), pages F632-F652, November.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Ekkehart Schlicht).
If references are entirely missing, you can add them using this form.